Aphali Pharmaceuticals Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 1933.
1933 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Aphali Pharmaceuticals Limited

Aphali Pharmaceuticals Limited, a active public limited company, was established on 16 October 1933 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U27239MH1933PLC002027. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.21 M.

It upholds a compliant status. Employing 17 professional, Its leadership includes Seema Shyam Kasat (Director), Aniruddha Shyamkumar Kasat (Director), Shyam Hariwilas Kasat (Managing Director). Past directors included Siddharth Shyamkumar Kasat. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 406, Auto Commerce House, Near Kennedy Bridge, Nana Chowk, Grant R, Oad, Mumbai, Maharashtra, 400007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U27239MH1933PLC002027

  • Registration Number

    002027

  • Incorporation Date

    16 October 1933

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.21 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.21 M
  • Company Age 92 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -7.50%
  • Profit Growth **** 9.57%
  • Ebitda **** -1065.74%
  • Net Worth -7.99%
  • Total Assets -10.88%
Company report

Aphali Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aphali Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aphali Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Seema Shyam Kasat Director 30 Jan 1996 Current
Aniruddha Shyamkumar Kasat Director 10 Mar 2016 Current
Shyam Hariwilas Kasat Managing Director 24 Apr 1979 Current
Siddharth Shyamkumar Kasat Director 10 Jul 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Mar 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aphali Pharmaceuticals.

Aphali Pharmaceuticals Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 7.5% decrease. The company also saw a slight improvement in profitability, with a 9.57% increase in profit. The company's net worth dipped by a decrease of 7.99%.

Aphali Pharmaceuticals revenue growth over time
Aphali Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -7.50%
*******
*******
*******
*******
Revenue from Operations
*******
 -14.62%
*******
*******
*******
*******
Total Assets
*******
 -10.88%
*******
*******
*******
*******
Profit or Loss
*******
 9.57%
*******
*******
*******
*******
Net Worth
*******
 -7.99%
*******
*******
*******
*******
EBITDA
*******
 -1065.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aphali Pharmaceuticals?

In 2017, Aphali Pharmaceuticals had a promoter holding of 48.24% and a public holding of 51.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aphali Pharmaceuticals?

Aphali Pharmaceuticals has a workforce of 17 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aphali Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aphali Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aphali Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Aphali Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Aphali Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Director Appointment

    Siddharth Shyamkumar Kasat was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Aniruddha Shyamkumar Kasat was appointed as a Director was appointed as a Director on 10 Mar 2016 & has been associated with this company since 10 years 20 days . was recorded as a recent event.

  • Director Appointment

    Progress on Seema Shyam Kasat was appointed as a Director was appointed as a Director on 30 Jan 1996 & has been associated with this company since 30 years 2 months . was documented.

  • Director Appointment

    The activity Shyam Hariwilas Kasat was appointed as a Managing Director was appointed as a Managing Director on 24 Apr 1979 & has been associated with this company since 46 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aphali Pharmaceuticals Limited?

The CIN of Aphali Pharmaceuticals Limited is U27239MH1933PLC002027.

Where is Aphali Pharmaceuticals Limited headquartered?

Aphali Pharmaceuticals Limited is headquartered at 406, Auto Commerce House, Near Kennedy Bridge, Nana Chowk, Grant R, Oad, Mumbai, Maharashtra, 400007.

When was Aphali Pharmaceuticals Limited incorporated?

Aphali Pharmaceuticals Limited was incorporated on 16 October 1933.

Who are the current directors of Aphali Pharmaceuticals Limited?

The current directors of Aphali Pharmaceuticals Limited are

What is the primary industry of Aphali Pharmaceuticals Limited?

The primary industry of Aphali Pharmaceuticals Limited is Manufacturing.

Is Aphali Pharmaceuticals Limited a listed company?

Aphali Pharmaceuticals Limited is unlisted.

What is the capital structure of Aphali Pharmaceuticals Limited?

The authorized capital of Aphali Pharmaceuticals Limited is ₹2.50 M, and the paid-up capital is ₹2.21 M.

What is the compliance status of Aphali Pharmaceuticals Limited?

The compliance status of Aphali Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available